Moving Away from One-Size-Fits-All: Assessing the Use of Pharmacogenetic-Guided Medication Therapy in Pediatric Patients with Chronic Pain
<b>Background/Objectives:</b> Pharmacogenetic (PGx) testing can predict drug efficacy, toxicity, and risk of adverse drug reactions (ADRs). However, PGx-guided prescribing for pediatric chronic pain is underutilized. <b>Methods</b>: We evaluated the rate of deviance from stan...
Saved in:
Main Authors: | Danielle Ruskin, Klaudia Szczech, Sierra Scodellaro, Naiyi Sun, Iris Cohn |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Children |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9067/12/6/721 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY
by: O. P. Bobrova, et al.
Published: (2018-07-01) -
Feasibility and acceptability of self-directed, remote dim-light melatonin onset collection in pediatric patients diagnosed with chronic pain
by: Nicole Tacugue, et al.
Published: (2025-07-01) -
The application of ketamine in pain management for sports injuries and other medical conditions - literature review
by: Katarzyna Nowicka, et al.
Published: (2025-07-01) -
Chronic scrotal pain: Pathogenesis, clinical phenotypes and modern treatment concept (clinical lecture)
by: K. B. Lelyavin
Published: (2022-09-01) -
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study
by: Noelia Pérez-Gómez, et al.
Published: (2025-07-01)